Yoshiyuki Yamakawa
Direktor/Vorstandsmitglied bei D. WESTERN THERAPEUTICS INSTITUTE, INC.
Ursprung des Netzwerks ersten Grades von Yoshiyuki Yamakawa
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 7 | |
| Public Company | Pharmaceuticals: Major | 4 | |
Hibiki Partners Co., Ltd.
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yoshiyuki Yamakawa
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Japan Innovative Therapeutics, Inc.
 Japan Innovative Therapeutics, Inc. BiotechnologyHealth Technology Part of D. Western Therapeutics Institute, Inc., Japan Innovative Therapeutics, Inc. develops and manufactures pharmaceutical products. The company is based in Nagoya City, Japan. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
ReproCELL USA, Inc.
 ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
BioServe Biotechnologies Ltd.
 BioServe Biotechnologies Ltd. BiotechnologyHealth Technology BioServe Biotechnologies Ltd. provides genomics products and services. It offers DNA, RNA extractions, genotyping, real time PCR and molecular diagnostic testing services. The company was founded by Ramakrishna Modali and Robert Skurla in 1989 and is headquartered in Beltsville, MD. | Biotechnology | Chairman Director/Board Member | |
| MAGiQ Therapeutics KK | Director/Board Member Director/Board Member | ||
ReproCELL Europe Ltd.
 ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
RC Partners, Inc.
 RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Investment Managers | Director/Board Member Director/Board Member | |
| Keio University | College/University | Undergraduate Degree Undergraduate Degree | |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Medical/Nursing Services | Director/Board Member | |
| University of Tsukuba | College/University | Undergraduate Degree | |
| Yokohama National University | College/University | Undergraduate Degree | |
Repro Curato KK
 Repro Curato KK Medical DistributorsDistribution Services Part of Curato Japan KK, Repro Curato KK is a Japanese company that distributes cosmetics, hair materials, and beauty products. The company is based in Tokyo, Japan. The company was founded in 2016. Repro Curato KK was acquired by Curato Japan KK on July 16, 2021. | Medical Distributors | Director/Board Member | |
Biopta Ltd.
 Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Stemgent, Inc. /New/
 Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Biotechnology | Chairman | |
| University of Tokyo | College/University | Doctorate Degree | |
| Mie University | College/University | Corporate Officer/Principal | |
| McKinsey & Co. (Japan) | Corporate Officer/Principal | ||
| RYUKA IP Law Firm | Corporate Officer/Principal | ||
| CYFUSE BIOMEDICAL K.K. | Biotechnology | Chief Executive Officer | |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| KOINOBORI Associate, Inc. | Comptroller/Controller/Auditor | ||
| ACUCELA INC | Pharmaceuticals: Major | Director/Board Member | |
| Tohoku University | College/University | Graduate Degree | |
Marunouchi Capital Co., Ltd.
 Marunouchi Capital Co., Ltd. Investment ManagersFinance Marunouchi Capital Co., Ltd. (Marunouchi Capital) is a private equity firm headquartered in Tokyo, Japan. The firm was founded in 2008 by Mitsubishi Corp. and Mitsubishi UFJ Securities Co., Ltd. | Investment Managers | Private Equity Investor | |
| SIGNPOST CORPORATION | Medical/Nursing Services | Director/Board Member |
Statistik
International
| Japan | 18 |
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 4 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 7 |
| Health Services | 4 |
| Commercial Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 29 |
| Chairman | 9 |
| Corporate Officer/Principal | 6 |
| Chief Administrative Officer | 5 |
| Investor Relations Contact | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Yoshiyuki Yamakawa
- Unternehmensverbindungen
